Tever O, Mentrup T, Chinn I, Ishikuma H, Fluhrer R, Schmitz M
Cell Mol Life Sci. 2025; 82(1):107.
PMID: 40072623
PMC: 11904002.
DOI: 10.1007/s00018-025-05645-5.
Rubin T, Bernier S, Hoon Lim L, Salman M, Leung E, Mhanni A
Front Immunol. 2025; 16:1557632.
PMID: 40061936
PMC: 11885508.
DOI: 10.3389/fimmu.2025.1557632.
Mentani A, Maresca M, Shiriaeva A
Cells. 2025; 14(4).
PMID: 39996750
PMC: 11853414.
DOI: 10.3390/cells14040277.
Hughes P, Lu L, Shi M, Syed D
Neurohospitalist. 2024; :19418744241310473.
PMID: 39712866
PMC: 11662338.
DOI: 10.1177/19418744241310473.
Chauvin S, Holley J, Poddar S, Miner C, Kumble L, Fu J
J Clin Immunol. 2024; 45(1):54.
PMID: 39671052
PMC: 11645301.
DOI: 10.1007/s10875-024-01846-y.
Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus.
Goldbach-Mansky R, Alehashemi S, de Jesus A
Nat Rev Rheumatol. 2024; 21(1):22-45.
PMID: 39623155
DOI: 10.1038/s41584-024-01184-8.
The prototypical interferonopathy: Aicardi-Goutières syndrome from bedside to bench.
Hofer M, Modesti N, Coufal N, Wang Q, Sase S, Miner J
Immunol Rev. 2024; 327(1):83-99.
PMID: 39473130
PMC: 11672868.
DOI: 10.1111/imr.13413.
cGAS activation in classical dendritic cells causes autoimmunity in TREX1-deficient mice.
Li T, Yum S, Wu J, Li M, Deng Y, Sun L
Proc Natl Acad Sci U S A. 2024; 121(38):e2411747121.
PMID: 39254994
PMC: 11420187.
DOI: 10.1073/pnas.2411747121.
A novel TREX1 inhibitor, VB-85680, upregulates cellular interferon responses.
Flowers S, Petronella B, McQueney M, Fanelli B, Eisenberg W, Uveges A
PLoS One. 2024; 19(8):e0305962.
PMID: 39178223
PMC: 11343403.
DOI: 10.1371/journal.pone.0305962.
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations in conjunction with systemic lupus erythematosus: Missed diagnosis or misdiagnosis?.
Wang X, Su L, Han J, Han Y, Yin Y, Huang J
Immun Inflamm Dis. 2024; 12(8):e1367.
PMID: 39119967
PMC: 11310852.
DOI: 10.1002/iid3.1367.
Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study.
Wang W, Spiegelman D, Rao P, Rhee R, Ford A, Miner J
J Clin Invest. 2024; 134(12).
PMID: 38950286
PMC: 11178534.
DOI: 10.1172/JCI180916.
Imbalance of the von Willebrand Factor - ADAMTS-13 axis in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S).
Braune M, Metelmann M, de Fallois J, Pfrepper C, Barrantes-Freer A, Hiller G
Neurol Res Pract. 2024; 6(1):32.
PMID: 38898536
PMC: 11188181.
DOI: 10.1186/s42466-024-00327-2.
Mining bone metastasis related key genes of prostate cancer from the STING pathway based on machine learning.
Li G, Zhao R, Xie Z, Qu X, Duan Y, Zhu Y
Front Med (Lausanne). 2024; 11:1372495.
PMID: 38835789
PMC: 11148254.
DOI: 10.3389/fmed.2024.1372495.
Inherited C-terminal TREX1 variants disrupt homology-directed repair to cause senescence and DNA damage phenotypes in Drosophila, mice, and humans.
Chauvin S, Ando S, Holley J, Sugie A, Zhao F, Poddar S
Nat Commun. 2024; 15(1):4696.
PMID: 38824133
PMC: 11144269.
DOI: 10.1038/s41467-024-49066-7.
Modeling of age-related neurological disease: utility of zebrafish.
Kanoh T, Mizoguchi T, Tonoki A, Itoh M
Front Aging Neurosci. 2024; 16:1399098.
PMID: 38765773
PMC: 11099255.
DOI: 10.3389/fnagi.2024.1399098.
Pathophysiology of cerebral small vessel disease: a journey through recent discoveries.
Dupre N, Drieu A, Joutel A
J Clin Invest. 2024; 134(10).
PMID: 38747292
PMC: 11093606.
DOI: 10.1172/JCI172841.
Ocular complications of SAVI: A unique case of bilateral uveitis and retinal vasculitis.
Menean M, Marchese A, Modorati G, Favale R, Boscia F, Bandello F
Am J Ophthalmol Case Rep. 2024; 34:102046.
PMID: 38633003
PMC: 11021826.
DOI: 10.1016/j.ajoc.2024.102046.
Mendelian Causes of Autoimmunity: the Lupus Phenotype.
Tusseau M, Khaldi-Plassart S, Cognard J, Viel S, Khoryati L, Benezech S
J Clin Immunol. 2024; 44(4):99.
PMID: 38619739
DOI: 10.1007/s10875-024-01696-8.
NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease.
Wilms A, de Boer I, Pelzer N, Int Veld S, Middelkoop H, Teunissen C
J Neurol. 2024; 271(7):4138-4145.
PMID: 38581544
PMC: 11233383.
DOI: 10.1007/s00415-024-12292-6.
Three Prime Repair Exonuclease 1 preferentially degrades the integration-incompetent HIV-1 DNA through favorable kinetics, thermodynamic, structural and conformational properties.
Prakash P, Khodke P, Balasubramaniam M, Davids B, Hollis T, Davis J
bioRxiv. 2024; .
PMID: 38562877
PMC: 10983988.
DOI: 10.1101/2024.03.19.585766.